Showing 641-650 of 2822 results for "".
News
https://practicalneurology.com/columns/practice-management/news/30633/Recurrent Stroke-Like Events Before Diagnosis of X-Linked Charcot—Marie—Tooth Disease
https://practicalneurology.com/diseases-diagnoses/neuromuscular/recurrent-stroke-like-events-before-diagnosis-of-x-linked-charcotmarietooth-disease/30235/Awareness of pathognomonic findings may prevent unnecessary tests and treatments.News
https://practicalneurology.com/columns/practice-management/news/30585/The MS Treatment Landscape: MSAA's 2014 MS Research Update Provides Vital Information to Medical Professionals, Members of the MS Community
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-ms-treatment-landscape-msaas-2014-emms-research-updateem-provides-vital-information-to-medical-professionals-members-of-the-ms-community/30677/New publication compiles the latest developments in MS research.Playing the Long Game: Current and Future Paths in TBI and Concussion
https://practicalneurology.com/diseases-diagnoses/tbi/playing-the-long-game-current-and-future-paths-in-tbi-and-concussion/30338/Advances in evaluation, risk stratification, and treatment of all severities of traumatic brain injury are shaping new approaches to management and prevention.MR CLEAN: A Close-Up Look
https://practicalneurology.com/diseases-diagnoses/stroke/mr-clean-a-close-up-look/30591/A co-principal investigator details the landmark stroke study and discusses how to avoid a turf war with competing specialties.MS Minute: Late-Breaking Data From ECTRIMS—Evobrutinib Safety and Efficacy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-late-breaking-data-from-ectrimsevobrutinib-safety-and-efficacy/30164/A potential new first-in-class treatment affects Bruton's tyrosine kinase.Treatment of Movement Disorders with Neuromodulation
https://practicalneurology.com/diseases-diagnoses/movement-disorders/treatment-of-movement-disorders-with-neuromodulation/32040/Effective surgical treatments are available for Parkinson disease, essential tremor, and dystonia.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Genetic Mechanisms of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/genetic-mechanisms-of-epilepsy/31588/Understanding gene and protein functions can sometimes guide diagnosis and treatment.